Joint Steering Committee (JSC). 11.1 The Parties shall promptly, and in any event within thirty (30) days from execution of this Agreement establish a joint steering committee (“Joint Steering Committee” or “JSC”) to review and provide input on all, Commercialization Plans of Product in the Territory. The JSC shall be comprised of an equal number of representatives from each of the Parties, including both development and commercial representatives of Parties. In addition, it is contemplated that senior executive and managerial personnel of each Party will serve as members of the JSC or will periodically participate in meetings of the JSC, when so required to assure that relevant matters are reviewed and jointly approved by the senior executive management of both Parties.
11.2 The JSC shall meet at least once each calendar quarter or as otherwise agreed to by the Parties. At least one meeting in each year shall be held in person, as face to face meetings.
11.3 The JSC shall exercise such authority in good faith in accordance with the terms of this Agreement. In the event that JSC is unable to reach a decision on any matter within thirty (30) days, the matter shall be referred to the top management of each Party for resolution.
11.4 The JSC shall review, and make recommendations with regards to Commercialization Plan to be performed by AEON hereunder. To that end, the JSC shall review; and make recommendations with regards to, the following; provided, however, that AEON shall, in its reasonable discretion, have the authority to make final decisions with respect to the following matters:
(a) the implementation of the plan for Drug Registration and strategy for filling application for Regulatory Approval for Products in the Territory;
(b) all regulatory aspects of Products, including but not limited to, each and every regulatory action, communication, and filing and submission including any supplements or amendments thereto to relevant Governmental Authorities in the Territory with respect to Products;
(c) schedule and implementation strategy for all applications for Regulatory Approval;
(d) coordinate the provision of expertise from both Parties to the JSC with respect to pre-clinical or clinical studies related to Product recommended by the JSC;
(e) suggest updates to, and implementation of, Marketing Plan; and
(f) the marketing, promotion, sale and/or distribution of Product.
11.5 Each Party may attend the JSC and other meetings together with interpreters, it being also agreed that the ag...
Joint Steering Committee (JSC). Promptly after the Effective Date the Parties shall establish and during the term of this Agreement the Parties shall operate a joint steering committee, which shall have the primary role in ensuring the overall success of the cooperation (“Joint Steering Committee”). The Joint Steering Committee will act as a forum between the Parties to ensure a smooth cooperation, regular business reviews and long-term planning. The JSC shall be comprised of an equal number of three (3) managing directors or board members of each Party. The initial JSC members shall be · For Shire: [*****] · For Centogene: [*****] The JSC shall meet at such time as the JSC shall agree from time to time with the aim to meet calendar quarterly, but shall meet at least every calendar half year. Shire shall designate the chairman of the JSC who shall be responsible to call the regular meetings and special meetings at either Party’s request. The meeting place shall alternate between the offices of Shire and Centogene, or as otherwise decided by the JSC. JSC meetings may be conducted in person, by telephone or videoconference, provided, however, that at least one (1) meeting per calendar year shall be held in person. Each Party shall provide the other Party with written notice of its new representatives for the JSC immediately upon replacement. Each Party may invite guests to the meetings, in order to discuss special technical or commercial topics. Shire shall keep accurate and complete minutes of the JSC meetings and shall circulate such minutes in English to Centogene within ten (10) Business Days after each meeting, and the Parties shall agree on the minutes of such meeting promptly. Each Party shall be responsible for the expenses incurred by its employees and its members of the JSC. All decisions of the JSC are to be made in good faith and in the best interest of the Agreement, and the Parties shall use their reasonable efforts to take decisions unanimously. The JSC shall not have any power to amend, modify or waive compliance with this Agreement. Each Party shall retain its rights, powers and discretion and no such rights, powers or discretion shall be delegated or vested in the JSC unless the Parties expressly so agree in writing.
Joint Steering Committee (JSC). The Joint Steering Committee established under the Global Master Services Agreement shall also ensure the overall success of the activities under the Agreement.
Joint Steering Committee (JSC). The JSC shall meet twice a year to provide a forum for the Parties to discuss activities under the Agreement, including the information reported by Allogene in Section II.1. above and any relevant updates thereto since the last JSC meeting. The JSC may also agree to form additional sub-committees to meet from time to time to conduct further discussions regarding specific activities under the Agreement.
Joint Steering Committee (JSC). The JSC is the operational body of the CBC Programme. The main responsibilities of the JSC are: ➢ To prepare the project fiches for the yearly programming exercise, to be forwarded to the JCC for adoption; ➢ To oversee the calls for proposal/Application Pack (drafted by the JTS), to be forwarded to respective IA for publication; ➢ To oversee the joint selection of projects; ➢ To supervise the activities of the Joint Technical Secretariat (JTS) and the Evaluation Committee; ➢ To approve the framework for the Joint Technical Secretariat’s tasks and the rules of procedures for the JTS to define the exact division of tasks To approve ➢ To review periodically, progress made towards achieving the specific (and quantified) objectives of the programme and to analyse the results of implementation (achievement of the targets set for the different measures). The JSC consists of: • representatives from the RO IA/CA and representatives from the BG IA/CA (in case of RO, one member shall be nominated from the CBC Regional Office Calarasi) • representatives of regional and local authorities with an equal representation of both RO and BG partners • representatives of the EC Delegations, acting as observers. The JSC will meet quarterly. It draws up and adopts its own rules of procedure.
Joint Steering Committee (JSC). Pfizer and Provider will establish a Joint Steering Committee (“JSC”) to carry out the obligations of each party as set forth in this Contract and specifically, to perform the following duties: ● Define and approve initial requirements, specifications and deliverables of the collaboration as set forth in Schedule B and report back to the parties; ● Manage the effective provision of timely and high quality Services; ● Seek improvements and refinements to the operations in the spirit of Continuous Improvement (CI); ● Any other duties as mutually agreed by the parties.
Joint Steering Committee (JSC). (a) As of the Effective Date, the Parties establish a Joint Steering Committee (the JSC), which shall have the responsibilities for overall coordination and oversight of the activities of the Parties under this Agreement and (as applicable) the Supply Agreement.
(b) The JSC's competencies and responsibilities shall include:
(i) discussing New Indications in the Licensed Territory to be pursued in Development of products containing or comprising the Licensed Compound;
(ii) reviewing, commenting on, and (when acceptable) approving the Clinical Development Plan and Technical Development Plan (including any proposed amendments or modifications thereto);
(iii) reviewing and discussing any reports and updates provided to it by the JCC to the extent permitted under applicable laws;
(iv) reviewing LICENSEE’s decision not to launch and Commercialize Licensed Products after obtaining regulatory approval in any country in the Licensed Territory;
(v) reviewing, commenting on, and (when acceptable) approving any amendments or modifications to Annex 4(g); and
(vi) otherwise reviewing and discussing each Party’s activities under this Agreement as needed to ensure efficient and effective progress towards achieving the goals and intention of the Agreement.
(c) The JSC can establish additional committees as it deems necessary to manage the business under the Agreement, which committees shall have the responsibilities and authority as designated by the JSC and shall be subject to the direct oversight and control of the JSC.
(d) The JSC may also have such other authority or make such other decisions as may be delegated to the JSC in any provision of this Agreement or any further written agreement of the Parties.
Joint Steering Committee (JSC). In due time after the Effective Date, the Parties will constitute a joint steering committee (the “Joint Steering Committee” or “JSC”). The JSC will have up to 6 (six) members, up to 3 (three) nominated by BiondVax, and up to 3 (three) nominated jointly by MPG and UMG. The initial JSC members are: ● for MPG/UMG: Prof. Xx. Xxxx Xxxxxxx (MPI-MS) and Prof. Xx. Xxxxxxxx Xxxxxxxxxxx (UMG), and, as they deem appropriate, a person from MPI-MS performing the Collaboration Project and ● for BiondVax: its CEO Xx. Xxxx Xxxxxxxx, CSO Dr. Xxxxx Ben YedidyaYedidia and Chairman of the Board of Director Xxxx Xxxxxxx Each of BiondVax and MPG/UMG may, in its sole discretion and at any time, upon written notice to the other Parties, withdraw one or more of the JSC members nominated by it, and nominate new members as replacement. Upon mutual agreement, the JSC may invite additional representatives from each of the Parties, or external persons, to join the JSC meetings in accordance with the actual agenda and needs. In its first meeting, the JSC shall agree upon a member that chairs the JSC.
Joint Steering Committee (JSC). (a) As of the Effective Date, the Parties establish a Joint Steering Committee (the JSC), which shall have the responsibilities for overall coordination and oversight of the activities of the Parties under this Agreement and (as applicable) the Supply Agreement.
(b) The JSC’s competencies and responsibilities shall include:
(i) discussing and agreeing on indications in the Field in the Licensed Territory to be pursued in Development of products containing or comprising the Licensed Compound in accordance with Section 2.2.2;
(ii) reviewing, commenting on, and (when acceptable) approving the Clinical Development Plan and Technical Development Plan (including any proposed amendments or modifications thereto);
(iii) exchanging appropriate information about the Development and Commercialization of the Licensed Products under this Agreement; and
(iv) otherwise reviewing and discussing each Party’s activities under this Agreement as needed to ensure efficient and effective progress towards achieving the goals and intention of the Agreement.
(c) The JSC can establish additional committees as it deems necessary to manage the business under the Agreement, which committees shall have the responsibilities and authority as designated by the JSC and shall be subject to the direct oversight and control of the JSC.
(d) The JSC may also have such other authority or make such other decisions as may be delegated to the JSC in any provision of this Agreement or any further written agreement of the Parties.
Joint Steering Committee (JSC)
